Norwich Clinical Services

Executive Summary

Norwich Clinical Services Private Limited is a global Contract Research Organization (CRO) headquartered in Bangalore, India, offering comprehensive clinical research and pharmacovigilance services across the full drug development lifecycle. With over a decade of experience since its founding in 2007, the company supports Phase I-IV clinical trials, bioanalytical studies, and specialized training programs for pharmaceutical and biotechnology clients. Its focus on multi-therapeutic area support rather than proprietary drug development positions it as a flexible partner for sponsors seeking cost-effective, high-quality clinical services. As an Indian CRO, Norwich benefits from the country's strong talent pool and regulatory expertise, enabling it to compete in the growing global clinical outsourcing market. The company's stage as a platform suggests it may be scaling operations or seeking strategic partnerships to expand its client base and service offerings.

Upcoming Catalysts (preview)

• Q3 2026New multi-year contract with a top-20 pharma company for Phase III trial management60% success
• Q2 2026Expansion of bioanalytical lab capabilities to support cell and gene therapy studies50% success
• Q4 2026Strategic partnership or acquisition to enter the US clinical research market30% success